Project Details
| Status | Active |
|---|---|
| Effective start/end date | 7/12/22 → 7/11/27 |
Funding
- Merck Sharp and Cohme Corporation: $12,750.00
A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older
- Porterfield, Laura (PI)
Project: Research project